Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 557, Issue 1, Pages 44-48Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2006.11.002
Keywords
cannabinoid CB1 receptor; FAAH [fatty acid amide hydrolase]; N-arachidonoyl ethanolamine (anandamide); pain; analgesia; marijuana
Categories
Funding
- NIDA NIH HHS [R01DA015197, P01DA009789, P50DA005274, T32DA007027, R01DA015683] Funding Source: Medline
Ask authors/readers for more resources
In the present study, we investigated whether anandamide produces its behavioral effects through a cannabinoid CB1 receptor mechanism of action. The behavioral effects of anandamide were evaluated in mice that lacked both fatty acid amide hydrolase (FAAH) and cannabinoid CB1 receptors (DKO) as compared to FAAH (-/-), cannabinoid CB1 (-/-), and wild type mice. Anandamide produced analgesia, catalepsy, and hypothermia in FAAH (-/-) mice, but failed to elicit any of these effects in the other three genotypes. In contrast, anandamide decreased locomotor behavior regardless of genotype, suggesting the involvement of multiple mechanisms of action, including its products of degradation. These findings indicate that the cannabinoid CB1 receptor is the predominant target mediating anandamide's behavioral effects. (c) 2006 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available